Alexandre Gaymard

9PUBLICATIONS
45CO-AUTHORS
Innate immunityDisease surveillanceEpidemiological modellingMedical infection agents (incl. prions)Instrumental methods (excl. immunological and bioassay methods)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 29, 2026
High Nasopharyngeal SARS-CoV-2 Load and Delayed Clearance in Hospitalized Patients With Blood Autoantibodies Neutralizing Type I Interferons.

|Aug 29, 2025
Community and Hospital-Based Laboratory Surveillance for Influenza, Respiratory Syncytial Virus, and SARS-CoV-2 During the 2023-2024 Season, Lyon, France.

Cécile Chauvel, Jean-Sébastien Casalegno, Benoit Visseaux

|Sep 05, 2024
Antiviral effect of Evusheld in COVID-19 hospitalized patients infected with pre-Omicron or Omicron variants: a modelling analysis of the randomized DisCoVeRy trial.

Maxime Beaulieu, Alexandre Gaymard, Clément Massonnaud

|Mar 28, 2024
Impact of the H274Y Substitution on N1, N4, N5, and N8 Neuraminidase Enzymatic Properties and Expression in Reverse Genetic Influenza A Viruses.

Alexandre Gaymard, Caroline Picard, Guilhem Vazzoler

|Sep 20, 2023
Association between SARS-CoV-2 viral kinetics and clinical score evolution in hospitalized patients.

Nadège Néant, Guillaume Lingas, Alexandre Gaymard

|May 27, 2023
SARS-CoV-2 N-Antigen Quantification in Respiratory Tract, Plasma and Urine: Kinetics and Association with RT-qPCR Results.

Delphine Parraud, Anne-Lise Maucotel, Maude Bouscambert

Pageof 2

Frequent Collaborators

4 joint publications

Jérémie Guedj

3 joint publications

Guillaume Lingas

3 joint publications

France Mentré

2 joint publications

Vanessa Escuret